Humaan Papilloma Virus (HPV) vaccin - 9 valent (type 6, 11, 16, 18, 31, 33, 45, 52 and 58)

Generic name
Humaan Papilloma Virus (HPV) vaccin - 9 valent (type 6, 11, 16, 18, 31, 33, 45, 52 and 58)
Brand name
ATC Code
J07BM03
Compare …

Humaan Papilloma Virus (HPV) vaccin - 9 valent (type 6, 11, 16, 18, 31, 33, 45, 52 and 58)

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information available.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

HPV vaccination (human papilloma virus types 6, 11, 16, 18, 31, 33, 45, 52 and 58)
  • Intramuscular
    • 9 years up to 15 years
      • 0.5 ml/dose according to the following schedules. 2-dose schedule: 1st dose at any time; 2nd dose 5-13 months after the 1st dose. If the second vaccine dose is administered earlier than 5 months after the first dose, a third dose should always be administered.
        3-dose schedule: 1st dose at any time; 2nd dose at least one month after the first dose; third dose at least 3 months after the second dose to be administered. The three doses should all be given within a 1-year period..
    • ≥ 15 years
      • 0.5 ml/dose according to the following schedule:. 3-dose schedule: 1st dose at any time; 2nd dose at least one month after the first dose; third dose at least 3 months after the second dose to be administered. The three doses should all be given within a 1-year period..
National vaccination programm: HPV (type 6, 11, 16, 18, 31, 33, 45, 52 and 58)
  • Intramuscular
    • 10 years
      • 0.5 ml/dose as follows:. 1e vaccination: 12 jaar
        2e vaccination: 6 months after 1st vaccination..

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

VIRAL VACCINES

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Encephalitis vaccines
J07BA02
J07BA01
Influenza vaccines
J07BB02
J07BB02
Hepatitis vaccines
J07BC20
J07BC02
J07BC01
Measles vaccines
J07BD52
Poliomyelitis vaccines
J07BF03
Rabies vaccines
J07BG01
Rota virus diarrhea vaccines
J07BH01
Varicella zoster vaccines
J07BK01
Yellow fever vaccines
J07BL01
Papillomavirus vaccines
J07BM02
Other viral vaccines
J07BX04
Covid-19 vaccines
J07BN01

References

  1. MSD VACCINS, SmPC Gardasil 9 (EU/1/15/1007/001-004) Rev 14; 06-05-2020, www.geneesmiddeleninformatiebank.nl
  2. RijksInstituut voor Volksgezondheid en Milieu (RIVM), Rijksvaccinatieprogramma: vaccinatieschema 2025, https://rijksvaccinatieprogramma.nl/vaccinaties/hpv

Changes

Therapeutic Drug Monitoring


Overdose